TMEM55B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.667000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.348400E-01
Normal-vs-Stage2
5.000800E-01
Normal-vs-Stage3
3.696400E-01
Normal-vs-Stage4
5.743400E-01
Stage1-vs-Stage2
4.137600E-01
Stage1-vs-Stage3
7.707400E-01
Stage1-vs-Stage4
6.534200E-01
Stage2-vs-Stage3
3.021000E-01
Stage2-vs-Stage4
8.661600E-01
Stage3-vs-Stage4
6.214800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.779400E-01
Normal-vs-AfricanAmerican
4.915000E-01
Normal-vs-Asian
5.281200E-01
Caucasian-vs-AfricanAmerican
6.281000E-01
Caucasian-vs-Asian
7.544600E-01
AfricanAmerican-vs-Asian
8.432400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.771800E-01
Normal-vs-Female
5.490400E-01
Male-vs-Female
9.597800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.228000E-01
Normal-vs-Age(41-60Yrs)
8.228800E-01
Normal-vs-Age(61-80Yrs)
4.440800E-01
Normal-vs-Age(81-100Yrs)
6.111000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.513400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.366200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.709600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.851700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.080000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.356600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.773400E-01
Normal-vs-Daily Drinker
9.343400E-01
Normal-vs-Weekly Drinker
5.059000E-01
Normal-vs-Occasional Drinker
8.905600E-01
Normal-vs-Social Drinker
5.121400E-01
Non Drinker-vs-Daily Drinker
1.055640E-01
Non Drinker-vs-Weekly Drinker
8.480600E-01
Non Drinker-vs-Occasional Drinker
1.198200E-01
Non Drinker-vs-Social Drinker
8.392400E-01
Daily Drinker-vs-Weekly Drinker
2.734000E-01
Daily Drinker-vs-Occasional Drinker
9.400200E-01
Daily Drinker-vs-Social Drinker
2.700000E-01
Weekly Drinker-vs-Occasional Drinker
2.799000E-01
Weekly Drinker-vs-Social Drinker
9.946600E-01
Occasional Drinker-vs-Social Drinker
2.801000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.545000E-01
Normal-vs-Grade 2
7.199800E-01
Normal-vs-Grade 3
7.209400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.381800E-01
Grade 1-vs-Grade 3
6.451400E-01
Grade 1-vs-Grade 4
3.545000E-01
Grade 2-vs-Grade 3
9.843600E-01
Grade 2-vs-Grade 4
7.199800E-01
Grade 3-vs-Grade 4
7.209400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.076800E-01
Normal-vs-NonDiabetic
6.819400E-01
Diabetic-vs-NonDiabetic
2.192200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.548600E-01
Normal-vs-NoPancreatitis
6.153000E-01
Pancreatitis-vs-NoPancreatitis
8.119800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.867200E-01
Normal-vs-N1
4.603800E-01
N0-vs-N1
1.911980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.789600E-01
Normal-vs-TP53-NonMutant
6.649600E-01
TP53-Mutant-vs-TP53-NonMutant
3.599800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
